KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $580.0 million.

  • Guardant Health's Cash & Equivalents fell 85.62% to $580.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $580.0 million, marking a year-over-year decrease of 85.62%. This contributed to the annual value of $525.5 million for FY2024, which is 5363.72% down from last year.
  • Latest data reveals that Guardant Health reported Cash & Equivalents of $580.0 million as of Q3 2025, which was down 85.62% from $629.1 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Cash & Equivalents ranged from a high of $1.1 billion in Q4 2023 and a low of $141.6 million during Q4 2022
  • Over the past 5 years, Guardant Health's median Cash & Equivalents value was $580.0 million (recorded in 2025), while the average stood at $594.1 million.
  • Per our database at Business Quant, Guardant Health's Cash & Equivalents tumbled by 8098.08% in 2022 and then soared by 70025.49% in 2023.
  • Quarter analysis of 5 years shows Guardant Health's Cash & Equivalents stood at $492.2 million in 2021, then crashed by 71.22% to $141.6 million in 2022, then soared by 700.25% to $1.1 billion in 2023, then crashed by 53.64% to $525.5 million in 2024, then grew by 10.37% to $580.0 million in 2025.
  • Its Cash & Equivalents was $580.0 million in Q3 2025, compared to $629.1 million in Q2 2025 and $698.6 million in Q1 2025.